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INTRODUCTION 
The current health profile of Western countries is 
characterised by longer life expectancies and an increas-
ing number of people who are affected by chronic dis-
eases. In the United States, roughly 5 out of 10 adults 
suffer from one or more chronic health conditions that 
are responsible for 7 out of 10 deaths each year. In Eu-
rope, chronic diseases affect 8 out of 10 adults who are 
65 years old and older [1]. The most prevalent of these 
illnesses include heart failure (HF), chronic obstructive 
pulmonary disease (COPD), diabetes mellitus (DM) 
and Parkinson’s disease (PD) [2].
HF affects 2.1% of the total population in the United 
States [3] and 2.2% of the total population in Europe 
[4]. The prevalence of COPD varies from 3.9% to 9.3% 
in the United States and from 4% to 10% in Europe [5]. 
COPD is certainly underestimated and is often under-
diagnosed [6]. The estimated prevalence of DM among 
adults is 9.3% in the United States and 8.3% in Europe. 
By the year 2035, the prevalence of DM is expected to 
increase to 10% in the general population and to 25% 
in the elderly population [7]. PD represents the second 
most common neurodegenerative disease internation-
ally. In the United States, approximately 60 000 people 
are diagnosed with PD each year, and in Europe, it af-
fects about 1.6% of those who are 65 years old or older 
[8].
The impact of HF, COPD, DM and PD on health-
care systems is relevant because these diseases are in-
curable, lifelong afflictions that absorb many formal and 
informal resources. In fact, most of the social support 
that is given to people affected by HF, COPD, DM and 
PD is provided by friends, family members and signifi-
cant others who exist outside of the healthcare system. 
This social support is considered essential for manag-
ing and reducing the progression of chronic diseases [9, 
10]. If this social support were unavailable, healthcare 
systems would not be able to meet the demand of care, 
and this inability could lead to serious consequences to 
patients’ health and influence health-related quality of 
life (QOL) [11]. QOL is defined as “a subjective per-
ception, influenced by the current health status, of the 
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Abstract
Purpose. This study aimed to evaluate the psychometric characteristics of the Multidi-
mensional Scale of Perceived Social Support (MSPSS) in patients with chronic diseases.
Methods. Patients (n = 236) with chronic diseases completed the MSPSS and the 36-
item Short Form Health Survey (SF-36) questionnaire. The MSPSS factorial structure 
was analysed using confirmatory factor analysis (CFA), and internal consistency reliabil-
ity was evaluated with Cronbach’s alpha, the factor score determinacy coefficient and the 
model-based internal consistency index. Concurrent validity was performed to correlate 
the MSPSS scores with the SF-36 scores. 
Results. CFA supported the three-factor structure of the MSPSS with optimal fit in-
dexes. Cronbach’s alpha, the factor score determinacy coefficient and the model-based 
internal consistency index were equal to or greater than 0.89. Concurrent validity sup-
ported the significant correlations between the MSPSS and SF-36 scores.
Conclusions. The MSPSS has supportive validity and reliability and can be used to 
evaluate the perceived social support received by chronic patients. 
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ability to perform those activities important for the in-
dividual” [12], p. 664].
Evidence shows that social support improves QOL, 
health outcomes and disease management for people 
with chronic diseases. For example, social support that 
is provided to people with HF has been associated with 
improved QOL, reduced hospital readmission [13], de-
creased cardiac symptoms [11], reduced emotional dis-
tress [13], increased adherence to treatment [14] and 
self-efficacy [15]. For COPD, social support has been 
associated with reduced hospitalisation and exacerbation 
of the disease and with improvements in anxiety, depres-
sion, well-being, health status [16] and disease manage-
ment. In patients with DM, social support can positively 
affect disease control [17]. In cases of PD, social support 
has been associated with positive well-being [18].
Several instruments have been developed to assess 
perceived social support. One of these instruments is 
the Multidimensional Scale of Perceived Social Sup-
port (MSPSS), a theoretically driven instrument that is 
widely used in research and practice. This instrument 
consists of three factors (Family, Friends and Signifi-
cant Others). It has been tested on several populations, 
specifically on students, teachers, pregnant women, 
healthy older adults and psychiatric patients, from vari-
ous countries. However, to our knowledge, only three 
existing studies have tested the psychometric character-
istics of MSPSS on patients affected by chronic condi-
tions (HF [19] and stroke [20]) and patients with an 
implantable cardioverter defibrillator (ICD) [11]. 
The study conducted on a sample of 446  ICDs pa-
tients [11], which used principal component analysis 
with varimax rotation, showed the same original three-
factor structure with the factors of Family, Friends and 
Significant Others. Convergent and divergent validity 
were supported in this study, with significant correla-
tions being found between the Crisis Support Scale 
(correlations from 0.40 to 0.61, p < 0.001) and the Hos-
pital Anxiety and Depression Scale (correlations from 
0.40 to 0.61, p < 0.001). Reliability, which was tested 
with Cronbach’s alpha, was 0.94 for the total scale.
The same results were obtained by testing the MSPSS 
validity in HF patients, and they confirmed the three-
factor structure with the factors of Family, Friends and 
Significant Others [19]. In this study, construct validity 
was tested through hypothesis testing, which showed a 
significant relationship between the MSPSS scores and 
depressive symptoms. Reliability, which was tested with 
Cronbach’s alpha, was supported in this study (0.94).
Only one study on patients with chronic diseases test-
ed the factorial validity of the MSPSS with confirmative 
factor analysis (CFA), which is considered the best ap-
proach for testing theoretically driven instruments such 
as the MSPSS [20]. This study was conducted solely on 
140 stroke patients [20] and tested both two-factor and 
three-factor structures of the MSPSS, and it showed 
better fit indices for the two-factor model than for the 
three-factor model. Concurrent validity was not tested 
in this study. Reliability, which was tested with Cron-
bach’s alpha, was 0.78 for the total scale. Reliability was 
supported with a test-retest and the kappa coefficient, 
which ranged from 0.67 to 1.
In conclusion, although several studies have tested 
the psychometric characteristics of the MSPSS, only 
three have tested this scale in patients with chronic 
diseases, and only one has tested its factorial struc-
ture with CFA and resulted in better fit indices for the 
two-factor model than the three-factor model. As psy-
chometrically sound instruments are important for re-
search and practice, this limited knowledge of the fac-
torial structure of the MSPSS in patients with chronic 
diseases represents a gap in the existing literature. 
Therefore, this study aimed to test the psychometric 
characteristics (factorial structure, concurrent validity 
and internal consistency reliability) of the MSPSS in a 
sample of patients with chronic diseases, such as HF, 
COPD, DM and PD. 
MATERIALS AND METHODS
Design
We used a cross-sectional study design. 
Setting and sample 
A convenience sample of patients with chronic dis-
eases was recruited in inpatient and outpatient settings 
from eight different regions of Italy. The patient inclu-
sion criteria were as follows: a) 18 years of age or older; 
b) a minimum of one-year diagnosis of one of the fol-
lowing chronic diseases: HF, COPD, DM or PD; and 
c) ability to read and understand the Italian language. 
The patient exclusion criterion was a diagnosis of de-
mentia or severe cognitive impairment after an evalua-
tion with the Montreal Cognitive Assessment test [21] 
that resulted in a score of equal to or less than 18. 
Instruments
The MSPSS [22] consists of 12 items that are grouped 
into three factors: Family (items 3, 4, 8 and 11), Friends 
(items 6, 7, 9 and 12) and Significant Others (items 
1, 2, 5 and 10). The respondents were asked to indi-
cate their level of agreement to each item by using a 
seven-point Likert scale ranging from 1 “very strongly 
disagree” to 7 “very strongly agree”. The scores of each 
subscale and the total scale ranged from 1 to 7, with 
higher scores indicating higher perceived social sup-
port. The Italian version of the MSPSS was translated 
by Prezza and Principato [23] following the backward-
forward translation method, and later validated through 
CFA on 382 university students confirming the original 
three-factor structure [24].
The 36-item Short Form Health Survey (SF-36) [25] 
is a self-administered instrument used to assess QOL 
using the following eight scales: physical functioning 
(PF), role physical (RP), bodily pain (BP), general 
health (GH), role emotional (RE), vitality (VT), mental 
health (MH) and social functioning (SF). The SF-36 is 
widely used to measure QOL in patients with chronic 
diseases [26, 27]. The validity and reliability of the Ital-
ian version of the SF-36 were tested in a previous study 
[28]. The scores of each SF-36 scale ranged from 0 to 
100, with higher scores indicating better QOL. As the 
literature showed that social support influences the 
quality of life in all the considered chronic diseases, the 
SF-36 was used to test the construct validity. 
Maddalena De Maria, Ercole Vellone, Angela Durante et al.
O
r
ig
in
a
l
 a
r
t
ic
l
e
s
 a
n
d
 r
e
v
ie
w
s
310
The socio-demographic and clinical characteristics of 
the participants were collected using an ad hoc ques-
tionnaire. Socio-demographic data included gender, 
age, region of residence, marital status, level of educa-
tion, employment status (employed or unemployed/re-
tired) and living conditions (living with others or alone).
The clinical data included disease stage (e.g., New 
York Heart Association Functional Classification for 
HF) and comorbidity evaluated using the Charlson co-
morbidity index (CCI) [29]. This instrument evaluates 
the number and the severity of 19 comorbid conditions, 
assigning a score from 1 to 6 for each condition. CCI 
scores range from 0 to 37, with higher scores indicating 
more comorbid conditions.
Data collection
The study participants were recruited according to 
the inclusion and exclusion criteria by trained research 
assistants who had identified eligible inpatients and 
outpatients from different healthcare institutions. Po-
tential participants were provided with detailed infor-
mation about the study and then invited to participate. 
Data collection was initiated only after the patients had 
signed an informed consent form.
Ethical consideration
The study received approval from the ethics commit-
tee of the university hospital that coordinated the study. 
The study’s research assistants ensured that participa-
tion in the study was voluntary and that data would 
be collected, analysed and reported under the strictest 
confidentiality. A written informed consent was ob-
tained from all participants included in the study.
Analysis 
Descriptive statistics (mean, frequency, percentage 
and standard deviation [SD]) were used to describe 
the clinical and sociodemographic characteristics of the 
participants. Skewness and kurtosis were used to evalu-
ate the normality of the MSPSS items [30]. 
CFA was used to test the dimensionality of the 
MSPSS with the three-factorial structure of Family, 
Friends and Significant Others. As these three fac-
tors are theoretically included under a wider second-
order factor, specifically social support, we also tested 
the factorial structure with the three first-order fac-
tors (Family, Friends and Significant Others) and a 
second-order factor that included the above three fac-
tors. CFA was conducted using the maximum likeli-
hood robust estimator to account for the non-normal 
distribution of the items [31]. To evaluate the adequa-
cy of the tested model, the following fit indices were 
considered: confirmatory fit index (CFI) [32] and the 
Tucker-Lewis index (TLI) [33], in which the values of 
equal to or greater than 0.95 indicate an excellent fit; 
standardized root mean square residual (SRMR), in 
which the values of equal to or less than 0.08 indicate a 
good fit; and root mean square error of approximation 
(RMSEA), in which the values of less than 0.06 indi-
cate a good fit. Traditional chi-square statistics were 
reported.  The concurrent validity of the MSPSS was 
evaluated by correlating the MSPSS factor scores with 
the SF-36 scale scores. Correlations were performed 
with Pearson’s r. 
The internal consistency reliability of MSPSS was as-
sessed with the Cronbach’s alpha coefficient for each 
subscale and for the overall scale. A coefficient greater 
than 0.70 indicates acceptable internal consistency, and 
a coefficient greater than 0.80 indicates good internal 
consistency [34]. The internal consistency of the fac-
tor solution was also evaluated with the factor score de-
terminant coefficient, which represents the correlation 
between the true and the estimated factor scores. The 
factor score determinant coefficient ranges from 0 to 1 
and describes how well the factor is measured (Muth-
én, 1998-2017). The larger the coefficient is (≥ 0.70), 
the more stable and reliable are the factors identified 
through factor analysis [35]. As the MSPSS is a mul-
tidimensional scale, the internal consistency reliability 
was also evaluated with the model-based internal con-
sistency index [36], which is an estimate of reliability 
for use in case of multidimensional or complex (pri-
mary- and second-order factors) scales, as the MSPSS 
has been hypothesised to be theoretically composed of 
three factors. A p value of equal to or less than 0.05 was 
considered statistically significant. Statistical analyses 
were conducted using Mplus version 7 [31] and IBM® 
SPSS® Statistics V22.
RESULTS
Clinical and sociodemographic characteristics  
of the participants
A total of 236 patients participated in the study, and 
were enrolled in seven regions of Central (77.5%) and 
Southern (22.5%) Italy. Nearly 81% were recruited in 
medical and surgical wards and the remaining patients 
in ambulatories of geriatrics, cardiology, endocrinology, 
and for chronic illnesses. Among the eligible patients, 
32 refused to participate due to lack of time (n = 20) or 
interest (n = 12).
 The mean age of the patients was 69 years (range: 
24-92), with 69.5% of the sample aged 65 years or over, 
and 54% of the patients were male. Nearly 57% of the 
patients were married, and 28% were widowed. About 
61% of the patients had elementary or middle school 
education. At least 13% of the sample was affected by 
HF, 30% by COPD, 53% by DM and 4% by PD. The 
mean CCI score was 3.4. Most of the participants were 
inpatients during the study (81%) (Table 1).
Item descriptive analysis  
Table 2 shows the SD, mean, skewness and kurtosis 
of the MSPSS items. Not all of the items were normally 
distributed, with eight showing a skewness index of 
greater than |1| and seven showing a kurtosis index of 
greater than |1|. All of the items had a mean score that 
was higher than the average value of four, which indi-
cates good perceived social support. The lowest values 
were for the four factor items of friends.
MSPSS validity 
CFA testing of the three-factor structure of Family, 
Friends and Significant Others yielded the following 
adequately fit indices: χ2 (51) = 91.69, p < 0.001, CFI 
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= 0.97, TLI = 0.96, RMSEA = 0.058 (90% Confidence 
Interval CI = 0.038-0.077) and SRMR = 0.04. All the 
factor loadings were equal to or greater than 0.79 and 
significant. As the three factors are theoretically con-
sidered to be factors of social support, a second-order 
factor was specified (Fig. 1). The fit indices of this re-
specified model were exactly the same as the three-fac-
tor model specified above. 
Table 3 presents the concurrent validity that was per-
formed by correlating the MSPSS scores with the SF-
36 scale scores. The Family factor score of MSPSS was 
significantly and positively correlated only with the SF-
36 scale score for VT. The Friends factor score of the 
MSPSS was significantly and positively correlated with 
all of the SF-36 scale scores. The Significant Others fac-
tor score of the MSPSS was positively and significantly 
correlated with the scale scores of PF and VT. The total 
MSPSS score was positively and significantly correlated 
with all of the SF-36 scale scores except for the RE scale 
score. 
People with chronic disease living with family showed 
higher scores than people living alone in the Family 
(5.91 vs 5.27, p < 0.001) and Significant Others (5.93 
vs 5.08, p < 0.001) support subscales and in the total 
scale (5.36 vs 4.92, p = 0.008). This finding shows con-
sistency between the perceived social support and the 
objective measures of actual support.
MSPSS reliability
Cronbach’s alpha was 0.92 for the Family factor, 0.96 
for the Friends factor, 0.93 for the Significant Others 
factor and 0.91 for the entire scale, showing an excel-
lent internal consistency. The factor score determinant 
coefficient was 0.97 for the Family factor, 0.98 for the 
Friends factor, 0.97 for the Significant Others factor 
and 0.89 for the entire scale. The internal consistency 
for the second-order factor structure, which was esti-
mated with Bentler’s model-based internal consistency, 
showed a high coefficient of 0.97 in the MSPSS. This 
result supports the use of scores for each factor and the 
combined scores of the 12 items of the MSPSS.
DISCUSSION
To our knowledge, this study was the first to test the 
psychometric properties of the MSPSS in Italians with 
chronic diseases and the second study to test the three 
theoretical factors of the MSPSS with CFA in patients 
with chronic diseases. Although CFA is considered the 
best approach for testing theoretically driven instru-
ments such as the MSPSS, only one study [20] used the 
CFA to test this instrument to date.
The results of our analysis showed that the three-fac-
torial structure of the MSPSS, with the factors of Fam-
ily, Friends and Significant Others, fit the data in our 
population of interest well. In the literature, the MSPSS 
factorial structure showed mixed results in patients af-
fected by chronic diseases. A three-factor structure was 
determined with the exploratory factor analysis in HF 
and ICD patients [11], whereas both two- and three-
factorial structures were tested and showed a better 
fit than the two-factor solution in stroke patients [20]. 
These mixed results in the MSPSS factorial structure 
Table 1
Sociodemographic and clinical characteristics of the sample (n 
= 236)
Variables Mean SD
Age 69.2 13.9
CCI 3.39 2.18
Year since diagnosis 11.11 7.89
Age classes n %
     ≤ 64
     65-75
     ≥ 76
72
69
95
30.5
29.2
40.3
Year since diagnosis classes
     ≤ 5
     6-10
     ≥ 11
71
75
90
30.1
31.8
38.1
Gender 
      Male
      Female
128
108
54.2
45.8
Education 
      None
      Elementary School
      Middle school
      High school
      University degree
16
77
67
63
13
6.8
32.6
28.4
26.7
5.5
Living conditions 
      Live alone
      Live with others
42
194
17.8
82.2
Occupation
      Retired/unemployed
      Employed
140
96
59.3
40.7
Origin 
      Central Italy
      Southern Italy
183
53
77.5
22.5
Diagnosis
      HF
      COPD
      DM
      PD
31
70
125
10
13.1
29.7
53.0
4.2
Setting 
      Outpatients
      Inpatients 
45
191
19.1
80.9
Severity diseases
Heart failure (NYHA class)
      I
      II
      III
      IV
COPD (mMRC grade)
      0
      1
      2
      3
      4
Diabetes
      Insulin treatment
      Oral treatment 
      Insulin and oral treatment
Parkinson’s disease (Hoehn and 
Yahr Stage) 
      nr
      1
      2
14
8
8
1
14
13
16
21
6
40
66
19
 
3
3
4
45.2
25.8
25.8
3.2
20.0
18.6
22.9
30.0
8.6
32.0
52.8
15.2
 
30
30
40
CCI: Charlson comorbidity index; HF: heart failure; COPD: chronic obstructive 
pulmonary disease; DM: diabetes mellitus; PD: Parkinson’s disease; mMRC: 
modified Medical Research Council; NYHA: New York Heart Association; SD: 
standard deviation; nr: not reported.
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emphasise the importance of testing the scale on spe-
cific populations before using it for clinical and research 
purposes. In fact, in several psychometric studies [37, 
38], investigators who used the MSPSS commented 
that social support is influenced by the cultural con-
text, and consequently, the MSPSS factorial structure 
should be tested in a specific population before using 
the MSPSS in research and clinical practice. For exam-
ple, in some Eastern cultures, the Family and Friends 
factors converged into a single factor. The investigators 
explained that in their culture, family and friends are 
close [37]. In addition, in a study conducted on Nige-
rian stroke patients, a two-factor model (the Family 
and Significant Others factors formed a single factor) 
fit the data better than a three-factor model [20]. In our 
sample, the three-factor structure was justified by the 
fact that in Italy, similar to other Western countries, the 
factors of Family and Significant Others are typically 
distinct [39, 40].
In this study, we also tested a model with a second-
order factor. This model fit the data well and made the 
MSPSS stronger from the theoretical and practical 
points of view. From a theoretical point of view, the 
three factors of Family, Friends and Significant Others 
belonged to the higher factor of social support because 
the second-order factor fit the data well. From a prac-
tical point of view, having a reliable second-order fac-
tor enables the consideration of the overall score when 
assessing the perceived level of support that a person 
receives from the general social network, and the sub-
scale scores can be used for a finer-grained evaluation 
on the source of social support (i.e. family, friends or 
significant others). To our knowledge, no existing study 
Table 2
Descriptive Analyses of MSPSS Items (n = 236)
MSPSS item Mean SD Skewness Kurtosis
1 SO There is a special person who is around when I am in need 5.85 1.29 -1.70 3.08
2 SO There is a special person with whom I can share my joys and sorrows 5.80 1.32 -1.34 1.51
3 FAM My family really tries to help me 5.89 1.13 -1.40 2.66
4 FAM I get the emotional help and support I need from my family 5.77 1.18 -1.24 1.92
5 SO I have a special person who is a real source of comfort to me 5.75 1.32 -1.16 0.97
6 FR My friends really try to help me 4.29 1.64 -0.41 -0.57
7 FR I can count on my friends when thing go wrong 4.20 1.64 -0.43 -0.59
8 FAM I can talk about my problems with my family 5.68 1.24 -1.43 2.49
9 FR I have friends with whom I can share my joys and sorrows 4.36 1.63 -0.39 -0.46
10 SO There is a special person in my life who cares about my feelings 5.7 1.24 -1.38 2.02
11 FAM My family is willing to help me make decisions 5.83 1.12 -1.17 1.89
12 FR I can talk about my problems with my friends 4.26 1.64 -0.43 -0.53
FAM: family; FR: friends; SO: significant others; MSPSS: multidimensional scale perceived social support; SD: standard deviation.
Table 3
Scores and correlations among the MSPSS factors
FAM FR SO Total 
MSPSS
PF SF-36 0.09 0.36*** 0.14* 0.30***
RP SF-36 0.04 0.30*** 0.12 0.24***
BP SF-36 0.08 0.20** 0.08 0.18**
GH SF-36 0.02 0.23*** 0.11 0.18**
VT SF-36 0.15* 0.24*** 0.22** 0.27***
SF SF-36 0.06 0.22** 0.07 0.19**
RE SF-36 -0.03 0.20** 0.02 0.11
MH SF-36 0.12 0.17** 0.11 0.17**
*** p < 0.001; ** p < 0.01; * p < 0.05
FAM:  Family; FR: Friends; SO: Significant others; MSPSS: Multidimensional 
scale perceived social support; PF SF-36: Physical functioning; RP SF-36: Role 
physical; BP SF-36: Bodily pain; GH SF-36: General health; VT SF-36: Vitality; SF 
SF-36: Social functioning; RE SF-36: Role emotional; MH SF-36: Mental health.
Figure 1
Confirmative factor analysis of the Multidimensional Scale of 
Perceived Social Support.
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of people with chronic diseases has tested and specified 
a factorial structure with a second-order factor for the 
MSPSS.
In this study, we tested the construct  validity of the 
MSPSS with the SF-36 subscales. Although we expect-
ed to find the significant correlation between the three 
MSPSS factors and the SF-36 subscales, we obtained 
mixed results. For example, the Family factor signifi-
cantly correlated only with the VT subscale, the Friends 
factor correlated with all of the SF-36 subscales, the 
Significant Others factor correlated with only the PF 
and VT subscales and the total MSPSS scale correlated 
with all of the SF-36 subscales except the RE subscale. 
These findings are difficult to interpret because previ-
ous studies that correlated the MSPSS with the SF-36 
in chronic diseases examined the total MSPSS score 
rather than the scores of each factor. To determine the 
factors affecting the quality of patient outcomes, social 
support along with each individual factor should be 
measured. For example, the current study revealed that 
family support appeared to affect VT but not the other 
dimensions of QOL.
Our study revealed that the internal consistency reli-
ability of the MSPSS is supported. We tested reliability 
with conventional methods, such as Cronbach’s alpha 
and internal consistency reliability, in addition to more 
innovative methods such as the model-based internal 
consistency index. Barbaranelli, Lee, Vellone and Riegel 
[41] suggested that with multidimensional scales, such 
as the MSPSS, Cronbach’s alpha might not be the best 
method for testing reliability. Nevertheless, the Cron-
bach’s alpha of the three factors and the entire scale 
was greater than 0.91, which indicates that the reliabil-
ity of the total scale and the MSPSS factors was excel-
lent. The supportive internal consistency reliability was 
also confirmed by the factor score determinacy coef-
ficient, which resulted in values that were even higher 
than those of Cronbach’s alpha. By testing multidimen-
sional reliability with the model-based internal consis-
tency index, we found that estimating the total score of 
the MSPSS was psychometrically appropriate. To our 
knowledge, this study is the only one to use an alternate 
estimate of reliability with the MSPSS, further support-
ing the strong reliability of the tool.
Several studies demonstrated that social support is 
important during the treatment of chronic conditions 
because it improves patient outcomes. For example, in 
HF patients, social support was proved to enhance their 
QOL, improve the prognosis of the disease and reduce 
its incidence, prevalence and mortality. In addition, 
high levels of social support were correlated with better 
self-care in patients with both HF [42] and DM [43]. 
For other conditions, such as HIV [44] and chronic ill-
nesses in the elderly [45], social support was found to 
facilitate problem solving, positive emotions and the re-
duction of negative ones [46]. In terms of behaviours, 
social support reduced the risk factors by promoting 
healthier lifestyles (better diet, less smoking, etc.) and 
the need for medical care. Moreover, social support was 
proved to improve adherence to treatment [47]. 
Limitations and strengths
This study has several limitations. The first limitation 
is that our sample was not homogeneous in terms of the 
enrolled patients. However, this limitation could also be 
considered a strength because the psychometric charac-
teristics of the MSPSS have been proven to be unaffect-
ed by it. The second limitation is that we used a cross-
sectional study with a convenience sample that included 
only four chronic diseases. Consequently, the results of 
this study could promote generalised precautions to pa-
tients who are affected by other chronic diseases. 
This study also has several strengths. First, it enriches 
the growing body of literature describing the psycho-
metric evaluation of the MSPSS in people with chronic 
diseases. Second, better methods (i.e. CFA) were used 
to evaluate the psychometric characteristics of theoreti-
cally driven instruments such as the MSPSS and the re-
liability.
CONCLUSIONS
The results of this study indicated that the MSPSS 
is a valid and reliable instrument that could be used to 
measure the perception of social support in people with 
chronic diseases. In accordance with previous studies, 
the original three-dimensional model of the MSPSS 
was confirmed, and its internal consistency proved to 
be excellent for both the total score and the scores of 
the three subscales [48, 49]. 
Implication 
Our study demonstrates that the MSPSS is valid and 
reliable and can certainly be used in clinical practice 
and research to measure the perceived social support in 
patients affected by chronic disease. As social support 
is a multidimensional construct, using each individual 
dimension score rather than the total global score is ad-
visable when clinicians want to identify the source of 
the social support that patients receive. For example, 
when the perceived social support from family is identi-
fied to be poor, healthcare professionals can tailor inter-
ventions to promote other forms of support, such as vol-
untary services, or create activities of social aggregation 
and sharing. By contrast, in cases of high social support 
from family, clinicians can consider the possible burden 
of the family derived from the continuous support of 
the care receiver.
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